Muhammed Murtaza

Title: Innovations by Inventor Muhammed Murtaza

Introduction

Muhammed Murtaza is an accomplished inventor based in Phoenix, Arizona. He has made significant contributions to the field of cancer research, particularly in the identification and treatment of lung cancer. With a total of six patents to his name, Murtaza's work has the potential to impact both human and veterinary medicine.

Latest Patents

One of Murtaza's latest patents focuses on the identification of HER2 mutations in lung cancer and methods of treatment. This invention provides methods for treating lung cancer, specifically pulmonary adenocarcinoma in canine subjects. The method involves assaying a biological sample from the canine, such as a tumor or plasma sample, for mutations in the HER2 gene. Notable mutations include HER2 V659E, HER2 A664T, and HER2 K676E. If these mutations are detected, the methods include treating the canine subject with a therapeutically effective amount of a HER2 inhibitor. For instance, the presence of HER2 V659E may indicate increased sensitivity to HER2 inhibitors like trastuzumab, neratinib, lapatinib, erlotinib, and pertuzumab. Another significant patent involves molecular tagging methods and sequencing libraries, which provide a tagged sequencing library and methods for tagging low abundance target sequences, facilitating the detection of these sequences.

Career Highlights

Murtaza has worked with notable organizations such as the Translational Genomics Research Institute and Cancer Research Technology Limited. His experience in these institutions has allowed him to collaborate on groundbreaking research and innovations in cancer treatment.

Collaborations

Murtaza has collaborated with esteemed colleagues, including Tania Contente-Cuomo and Nitzan Rosenfeld. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Muhammed Murtaza's innovative work in cancer research exemplifies the impact of dedicated inventors in the medical field. His patents not only advance scientific knowledge but also offer potential treatment options for both humans and animals.